209 related articles for article (PubMed ID: 35662448)
1. Anaplastic Thyroid Cancer: New Horizons and Challenges.
Maniakas A; Zafereo M; Cabanillas ME
Endocrinol Metab Clin North Am; 2022 Jun; 51(2):391-401. PubMed ID: 35662448
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Management of Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
[TBL] [Abstract][Full Text] [Related]
3. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
[TBL] [Abstract][Full Text] [Related]
4. Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report.
Zheng L; Li L; He Q; Wang M; Ma Y; Zhu J; Li Y; Fu X; Zhang Y
Medicine (Baltimore); 2021 Aug; 100(32):e26138. PubMed ID: 34397868
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Management of Anaplastic Thyroid Cancer.
Alobuia W; Gillis A; Kebebew E
Curr Treat Options Oncol; 2020 Aug; 21(10):78. PubMed ID: 32767129
[TBL] [Abstract][Full Text] [Related]
6. Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer.
Li W; Li Y; Li J; Pang H
Technol Cancer Res Treat; 2023; 22():15330338231169870. PubMed ID: 37122242
[TBL] [Abstract][Full Text] [Related]
7. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
Smith N; Nucera C
J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569
[TBL] [Abstract][Full Text] [Related]
8. [Personalized approach to anaplastic thyroid carcinoma].
Wächter S; Bartsch DK; Maurer E
Chirurgie (Heidelb); 2024 Mar; 95(3):192-199. PubMed ID: 37973622
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Thyroid Carcinoma, Version 2.2015.
Haddad RI; Lydiatt WM; Ball DW; Busaidy NL; Byrd D; Callender G; Dickson P; Duh QY; Ehya H; Haymart M; Hoh C; Hunt JP; Iagaru A; Kandeel F; Kopp P; Lamonica DM; McCaffrey JC; Moley JF; Parks L; Raeburn CD; Ridge JA; Ringel MD; Scheri RP; Shah JP; Smallridge RC; Sturgeon C; Wang TN; Wirth LJ; Hoffmann KG; Hughes M
J Natl Compr Canc Netw; 2015 Sep; 13(9):1140-50. PubMed ID: 26358798
[TBL] [Abstract][Full Text] [Related]
10. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I; Lam AK
Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in anaplastic thyroid cancer management.
Hamidi S; Maniakas A
Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):259-264. PubMed ID: 37410453
[TBL] [Abstract][Full Text] [Related]
13. Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling.
Khan SA; Ci B; Xie Y; Gerber DE; Beg MS; Sherman SI; Cabanillas ME; Busaidy NL; Burtness BA; Heilmann AM; Bailey M; Ross JS; Sher DJ; Ali SM
Head Neck; 2019 Jun; 41(6):1928-1934. PubMed ID: 30758123
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
Maniakas A; Dadu R; Busaidy NL; Wang JR; Ferrarotto R; Lu C; Williams MD; Gunn GB; Hofmann MC; Cote G; Sperling J; Gross ND; Sturgis EM; Goepfert RP; Lai SY; Cabanillas ME; Zafereo M
JAMA Oncol; 2020 Sep; 6(9):1397-1404. PubMed ID: 32761153
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic thyroid carcinoma: review of treatment protocols.
Tiedje V; Stuschke M; Weber F; Dralle H; Moss L; Führer D
Endocr Relat Cancer; 2018 Mar; 25(3):R153-R161. PubMed ID: 29295821
[TBL] [Abstract][Full Text] [Related]
17. Management of the compromised airway and role of tracheotomy in anaplastic thyroid carcinoma.
Mani N; McNamara K; Lowe N; Loughran S; Yap BK
Head Neck; 2016 Jan; 38(1):85-8. PubMed ID: 25215461
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature.
Lowe NM; Loughran S; Slevin NJ; Yap BK
ScientificWorldJournal; 2014; 2014():674583. PubMed ID: 25184150
[TBL] [Abstract][Full Text] [Related]
19. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic advances in anaplastic thyroid cancer: a current perspective.
Saini S; Tulla K; Maker AV; Burman KD; Prabhakar BS
Mol Cancer; 2018 Oct; 17(1):154. PubMed ID: 30352606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
